Epithalon vs. Thymalin: Comparative Peptide Bioregulator Research

Background: Khavinson's Bioregulator System

Vladimir Khavinson's group at the Saint Petersburg Institute of Bioregulation and Gerontology developed a complete system of tissue-specific peptide bioregulators over four decades. Each peptide is derived from a specific organ and is proposed to restore gene expression in that corresponding tissue as levels decline with age.

Of the 20+ bioregulators studied, Epithalon (pineal-derived) and Thymalin (thymus-derived) are the two with the most extensive published research records — and the two most frequently investigated in combination.

Epithalon (AEDG): Pineal Gland Bioregulator

Source: Derived from epithalamin, a polypeptide extracted from bovine pineal glands Sequence: Ala-Glu-Asp-Gly (4 amino acids) Molecular weight: ~432 Da

Primary Research Targets

• Telomere biology: hTERT upregulation, measurable telomere elongation in somatic cells
• Melatonin restoration: AANAT upregulation, restored nocturnal melatonin peaks in aging rodents
• Longevity: 8-13% mean lifespan extension in rodent studies
• Tumor suppression: Reduced spontaneous tumor incidence in aging models
• Circadian regulation: Normalized locomotor rhythms in aged animals

Mechanistic Specificity

Epithalon acts primarily through transcriptional regulation — specifically hTERT promoter activity and DNA methylation changes. Its effects are upstream and genomic, making it a foundational longevity research tool.

Thymalin: Thymus Bioregulator

Source: Derived from thymalin extract from bovine thymus gland Type: Polypeptide mixture (not a defined single sequence like Epithalon) Key active fractions: Various di-peptides and tri-peptides

Primary Research Targets

• Thymic involution reversal: Preserved thymic architecture in aging rodents
• T-cell output: Maintained naive T-cell production from thymus
• NK cell function: Enhanced natural killer cell cytotoxicity in aging models
• Immune response: Restored delayed-type hypersensitivity responses
• Longevity: Combined with Epithalon in studies showing additive lifespan benefit

Mechanistic Specificity

Thymalin works primarily at the immune level — its target organ is the thymus, and its downstream effects cascade through T-cell maturation, NK activation, and cytokine balance normalization.

Head-to-Head Comparison

Parameter

Epithalon

Thymalin

Source tissue	Pineal gland	Thymus
Structure	Defined tetrapeptide (AEDG)	Polypeptide mixture
MW	~432 Da	Variable
Telomere research	Primary target	Not documented
Melatonin	Restores nocturnal peaks	Indirect (via immune)
T-cell function	Indirect restoration	Primary target
NK cell activity	Documented	Primary target
Tumor suppression	Strong evidence	Strong evidence
Lifespan extension	8-13% (rodent)	Additive with Epithalon
Clinical data	Khavinson cohorts	Khavinson cohorts

Combined Protocol Research

Khavinson's group published several studies using Epithalon and Thymalin in combination. The rationale:

• Complementary targets: Epithalon addresses genomic/telomere aging; Thymalin addresses immune aging
• Both decline together: Pineal and thymic involution parallel each other with age
• Additive lifespan effect: Rodent data suggests greater lifespan benefit with combination vs. either agent alone
• Immune-longevity link: Immunosenescence (Thymalin's target) accelerates cancer and infection mortality; Epithalon's tumor suppression and Thymalin's immune enhancement are mechanistically complementary

Summary

For researchers studying multi-pathway longevity approaches, Epithalon and Thymalin represent the two most validated Khavinson bioregulators with distinct, complementary mechanisms. Epithalon is the better-characterized individual agent with a defined sequence and published telomere data; Thymalin provides the immune axis that Epithalon does not address directly.

Epithalon 50mg from Apollo Peptide Sciences — for laboratory research only.